DD265141A5 - Verfahren zur herstellung einer antiallergisch und entzuendungshemmende wirkende verbindung - Google Patents
Verfahren zur herstellung einer antiallergisch und entzuendungshemmende wirkende verbindung Download PDFInfo
- Publication number
- DD265141A5 DD265141A5 DD87303578A DD30357887A DD265141A5 DD 265141 A5 DD265141 A5 DD 265141A5 DD 87303578 A DD87303578 A DD 87303578A DD 30357887 A DD30357887 A DD 30357887A DD 265141 A5 DD265141 A5 DD 265141A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- compounds
- hydrogen
- nmr
- methyl
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Fats And Perfumes (AREA)
- External Artificial Organs (AREA)
- Indole Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13347086 | 1986-06-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
DD265141A5 true DD265141A5 (de) | 1989-02-22 |
Family
ID=15105525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD87303578A DD265141A5 (de) | 1986-06-09 | 1987-06-05 | Verfahren zur herstellung einer antiallergisch und entzuendungshemmende wirkende verbindung |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0249407B1 (xx) |
JP (1) | JPH0623199B2 (xx) |
KR (1) | KR900000552B1 (xx) |
CN (1) | CN1015334B (xx) |
AT (1) | ATE60596T1 (xx) |
AU (1) | AU586337B2 (xx) |
CA (1) | CA1305151C (xx) |
DD (1) | DD265141A5 (xx) |
DE (1) | DE3767778D1 (xx) |
DK (1) | DK288287A (xx) |
ES (1) | ES2031892T3 (xx) |
FI (1) | FI87924C (xx) |
GR (1) | GR3001584T3 (xx) |
HU (1) | HU198451B (xx) |
IE (1) | IE60015B1 (xx) |
NO (1) | NO168246C (xx) |
PL (1) | PL150631B1 (xx) |
PT (1) | PT85035B (xx) |
SU (1) | SU1757464A3 (xx) |
YU (1) | YU45423B (xx) |
ZA (1) | ZA874046B (xx) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4720297A (en) * | 1985-09-27 | 1988-01-19 | Sumitomo Chemical Company, Limited | Benzothiazolones, and their production and use as herbicides |
JPH0283376A (ja) * | 1988-09-19 | 1990-03-23 | Pfizer Pharmaceut Co Ltd | ベンゾオキサゾロン誘導体および抗アレルギー又は抗炎症組成物 |
IL93473A0 (en) * | 1989-02-28 | 1990-11-29 | Pfizer | Antiinflammatory benzoxazolones |
JPH0678327B2 (ja) * | 1989-07-20 | 1994-10-05 | ファイザー製薬株式会社 | 4,5,6,7,―四置換ベンゾオキサゾロン類 |
JPH0729998B2 (ja) * | 1990-01-22 | 1995-04-05 | ファイザー製薬株式会社 | 新規ベンゾキノン化合物およびその組成物 |
AU6966696A (en) * | 1995-10-05 | 1997-04-28 | Warner-Lambert Company | Method for treating and preventing inflammation and atherosclerosis |
US6001866A (en) * | 1995-10-05 | 1999-12-14 | Warner-Lambert Company | Method for treating and preventing inflammation and atherosclerosis |
US5972980A (en) * | 1995-10-05 | 1999-10-26 | Warner-Lambert Company | Method for treating and preventing inflammation and atherosclerosis |
WO2002070478A1 (en) | 2001-03-06 | 2002-09-12 | Astrazeneca Ab | Indolone derivatives having vascular-damaging activity |
DE10210779A1 (de) * | 2002-03-12 | 2003-10-09 | Merck Patent Gmbh | Cyclische Amide |
TW200508197A (en) * | 2003-03-31 | 2005-03-01 | Ucb Sa | Indolone-acetamide derivatives, processes for preparing them and their uses |
US7270805B1 (en) * | 2006-03-30 | 2007-09-18 | Conopco, Inc. | Skin lightening agents, compositions and methods |
WO2010090680A1 (en) * | 2008-12-15 | 2010-08-12 | Wyeth Llc | Substituted oxindole cb2 agonists |
JP5964965B2 (ja) * | 2011-08-18 | 2016-08-03 | ドクター レディズ ラボラトリーズ リミテッド | コレステリルエステル転送タンパク質(cetp)インヒビターとしての置換複素環式アミン化合物 |
DK2852581T3 (en) | 2012-05-21 | 2016-08-01 | Dr August Wolff Gmbh & Co Kg Arzneimittel | NOVEL 1,3-benzoxazol-2 (3H) -ONES and Their Use as médicaments AND COSMETICS |
EP3932395A1 (en) * | 2020-07-03 | 2022-01-05 | Dr. August Wolff GmbH & Co. KG Arzneimittel | Stable emulsion containing an active pharmaceutical ingredient based on n(3-methyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)dodecanamide, production and use |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5663972A (en) * | 1979-10-30 | 1981-05-30 | Tetsujirou Masuko | Preparation of novel benzothiazolone derivative containing novel heterocyclic quaternary salt |
DE3017977A1 (de) * | 1980-05-10 | 1981-11-19 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue substituierte 2(3h)-benzothiazolone |
DE3042481A1 (de) * | 1980-11-11 | 1982-06-16 | A. Nattermann & Cie GmbH, 5000 Köln | (omega)-(2-oxo-benzazolinyl)-alkansaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
GB8325370D0 (en) * | 1983-09-22 | 1983-10-26 | Fujisawa Pharmaceutical Co | Benzoxazoline and benzothiazoline derivatives |
US4569942A (en) * | 1984-05-04 | 1986-02-11 | Pfizer Inc. | N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents |
US4690943A (en) * | 1984-09-19 | 1987-09-01 | Pfizer Inc. | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds |
-
1987
- 1987-06-04 DK DK288287A patent/DK288287A/da not_active Application Discontinuation
- 1987-06-05 AT AT87304983T patent/ATE60596T1/de not_active IP Right Cessation
- 1987-06-05 DE DE8787304983T patent/DE3767778D1/de not_active Expired - Fee Related
- 1987-06-05 CA CA000538939A patent/CA1305151C/en not_active Expired - Fee Related
- 1987-06-05 NO NO872382A patent/NO168246C/no unknown
- 1987-06-05 ZA ZA874046A patent/ZA874046B/xx unknown
- 1987-06-05 IE IE150587A patent/IE60015B1/en not_active IP Right Cessation
- 1987-06-05 AU AU73878/87A patent/AU586337B2/en not_active Ceased
- 1987-06-05 ES ES87304983T patent/ES2031892T3/es not_active Expired - Lifetime
- 1987-06-05 EP EP87304983A patent/EP0249407B1/en not_active Expired - Lifetime
- 1987-06-05 DD DD87303578A patent/DD265141A5/de not_active IP Right Cessation
- 1987-06-08 FI FI872555A patent/FI87924C/fi not_active IP Right Cessation
- 1987-06-08 CN CN87104099A patent/CN1015334B/zh not_active Expired
- 1987-06-08 PL PL1987266132A patent/PL150631B1/pl unknown
- 1987-06-08 JP JP62142779A patent/JPH0623199B2/ja not_active Expired - Lifetime
- 1987-06-08 PT PT85035A patent/PT85035B/pt unknown
- 1987-06-08 SU SU874202723A patent/SU1757464A3/ru active
- 1987-06-08 YU YU1049/87A patent/YU45423B/xx unknown
- 1987-06-08 KR KR1019870005780A patent/KR900000552B1/ko not_active IP Right Cessation
- 1987-06-08 HU HU872613A patent/HU198451B/hu not_active IP Right Cessation
-
1991
- 1991-03-08 GR GR91400282T patent/GR3001584T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69013836T2 (de) | Benzimidazolverbindungen und deren Anwendung. | |
DE69725465T2 (de) | 6-phenylpyridyl-2-amin-derivate verwendbar als nos-inhibitoren | |
DE69200378T2 (de) | Indolderivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel. | |
EP0026848B1 (de) | Tetralinderivate, ihre Herstellung und Heilmittel, welche diese Verbindungen enthalten | |
DE69524246T2 (de) | 1,2,3,4-Tetrahydroquinoxalindion Derivate und ihre Verwendung als Glutamat Rezeptor Antagonisten | |
DD265141A5 (de) | Verfahren zur herstellung einer antiallergisch und entzuendungshemmende wirkende verbindung | |
DE3047142C2 (de) | Basische 1,7,7-Trimethylbicyclo[2,2,1]heptyläther, Verfahren zur Herstellung derselben und diese enthaltende Arzneimittel | |
DE3026201C2 (xx) | ||
EP0272534A2 (de) | 8-Substituierte 2-Aminotetraline | |
DE3522604A1 (de) | Neue feste formen von 2-(gamma)thoxy-4-(n-(1-(2-piperidino-phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl)-benzoesaeure, diese formen enthaltende arzneimittel und verfahren zu ihrer herstellung | |
DE69101449T2 (de) | 1,3-Dicarbonylverbindungen und ihre Verwendung. | |
DE3617183A1 (de) | Substituierte benzylether | |
EP0183159A2 (de) | 1-Heteroaryl-4-aryl-pyrazolin-5-one zur Verwendung als Arzneimittel | |
DE69530988T2 (de) | Benzimidazolderivate mit dopaminerger wirkung | |
DD264919A5 (de) | Verfahren zur herstellung von 5-hydroxy-3-aminochromanen | |
DE69105278T2 (de) | Neue aminobenzosultamderivate und ihre verwendung als lipoxygenase hemmer. | |
DE3856501T2 (de) | Schlafverbesserungsmittel | |
EP0297380B1 (de) | Indolylpropanole, Verfahren zu ihrer Herstellung und ihre Verwendung sowie die Verbindungen enthaltende Zubereitungen | |
DE60115997T2 (de) | 1,1- und 1,2-disubstituierte Cyclopropane, Verfahren zu deren Herstellung und deren pharmazeutischen Zusammensetzungen | |
DE3586411T2 (de) | Dopamin-antagoniste. | |
DE69014798T2 (de) | Thionaphthalen-derivate, verfahren zur herstellung und antiallergisches mittel daraus. | |
DE69227596T2 (de) | Alkoxyphenylalkylaminderivat | |
DE3900028A1 (de) | Gegebenenfalls am phenylrest halogen- und/oder alkyl- und/oder alkoxy- oder methylendioxysubstituierte, 5,5-di-(methyl)-3-(phenylvinyl)-1-(substituiert amino-alkoxy-imino)-cyclohex-2-enderivate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel | |
DE3014813A1 (de) | 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)benzoesaeure-derivate | |
EP0018360A1 (de) | N-(5-Methoxybentofuran-2-ylcarbonyl)-N'-benzylpiperazin und Verfahren zu dessen Herstellung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENJ | Ceased due to non-payment of renewal fee |